Specie Bio - About the company
Specie Bio is a funded company based in United States, founded in 2022 by Fergus Chan. It operates as a Digital platform to search and get access to samples and data. The company has 102 active competitors, including 14 funded and 7 that have exited. Its top competitors include companies like ArcaScience, Biorelate and ScienceIO.
Company Details
Digital platform to search and get access to samples and data. It offers BioExchange platform that enables users to find and access samples and data across an aggregated inventory from network of providers including hospitals, research institutes, medical centers and biobanks.
Key Metrics
Founded Year
2022
Location
Stage
Funding Raised
Ranked
64th among 102 active competitors
Employee Count
7 as on Aug 31, 2026
Similar Companies
Legal entities associated with Specie Bio
Specie Bio is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
SPECIE BIO INC CIN: 7196809 , United States, Active | Dec 20, 2022 | - | - | - |
Sign up to download Specie Bio's company profile
Specie Bio's funding and investors
Specie Bio is a funded company. Specie Bio has 1 institutional investor.
Specie Bio's founders and board of directors
Founder? Claim ProfileThe founders of Specie Bio is Fergus Chan. Fergus Chan is the CEO of Specie Bio.
Here are the details of Specie Bio's key team members:
- Fergus Chan: Founder & CEO of Specie Bio. Contact Info: 1 email address
View details of Specie Bio's Founder profiles and Board Members
Specie Bio's employee count trend
Specie Bio has 7 employees as of Aug 26. Here is Specie Bio's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Specie Bio's Competitors and alternates
Top competitors of Specie Bio include ArcaScience, Biorelate and ScienceIO. Here is the list of Top 10 competitors of Specie Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | ArcaScience 2018, Paris (France), Seed | Developer of AI models for patient-centric insights in drug development | $7M | 51/100 | |
2nd | Biorelate 2014, Manchester (United Kingdom), Series A | Developer of an artificial intelligence platform for biomedical literature curation and knowledge graph construction | $8.74M | 47/100 | |
3rd | ScienceIO 2020, Boston (United States), Acquired | Provider of AI solutions transforming medical text into enriched healthcare data | $8M | 46/100 | |
4th | Kudos 2013, Oxford (United Kingdom), Series A | Provider of research communication and showcase services. It helps researchers effectively communicate their work to a broader audience. The company offers tools and resources to enhance research visibility and impact. Services include creating engaging narratives around research findings and facilitating their dissemination across various platforms. This improves the reach and understanding of scientific discoveries. | $2.5M | 45/100 | |
5th | Longenesis 2017, Riga (Latvia), Seed | Digital platform for healthcare research and patient engagement | $1.19M | 43/100 | |
6th | Citelighter 2011, New York City (United States), Acquired | Digital writing solution for K-20 students | $6.58M | 42/100 | |
7th | Developer of 3D medical animations and augmented, mixed, virtual reality | - | - | 42/100 | |
8th | Protocols.io 2012, Berkeley (United States), Seed | Life science protocol repository | $500K | 41/100 | |
9th | Pharmacodia 2013, Beijing (China), Series B | Online database solutions for pharmaceutical R&D | $14.5M | 40/100 | |
10th | Collaborative Drug Discovery 2004, Burlingame (United States), Series A | Biological and chemical database to manage private and external data | - | 39/100 | |
64th | Specie Bio 2022, United States, Funding Raised | Digital platform to search and get access to samples and data | - | - | 17/100 |
Looking for more details on Specie Bio's competitors? Click here to see the top ones
Specie Bio's Investments and acquisitions
Specie Bio has made no investments or acquisitions yet.
Reports related to Specie Bio
Here is the latest report on Specie Bio's sector:
Are you a Founder ?
FAQs about Specie Bio
Explore our recently published companies
- Supa Nutri - Blantyre based, 2006 founded, Unfunded company
- Ecole Superieure - Etudes superieures au Maroc - Morocco based, 2015 founded, Unfunded company
- App2Track - Nijkerk based, 2016 founded, Unfunded company
- Want Studio - Italy based, Unfunded company
- Reklamhang - Unfunded company
- Mentoring Education - Natal based, 2019 founded, Seed company